269 related articles for article (PubMed ID: 9112381)
1. Dopamine D4 receptor-mediated inhibition of cyclic adenosine 3',5'-monophosphate production does not affect prolactin regulation.
Sanyal S; Van Tol HH
Endocrinology; 1997 May; 138(5):1871-8. PubMed ID: 9112381
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the forms of the dopamine D2 receptor expressed in GH4C1 cells.
Burris TP; Freeman ME
Proc Soc Exp Biol Med; 1994 Mar; 205(3):226-35. PubMed ID: 8171043
[TBL] [Abstract][Full Text] [Related]
3. Vasoactive intestinal polypeptide and pituitary adenylate cyclase-activating polypeptides stimulate mitogen-activated protein kinase in the pituitary cell line GH4C1 by a 3',5'-cyclic adenosine monophosphate pathway.
Le Péchon-Vallée C; Magalon K; Rasolonjanahary R; Enjalbert A; Gérard C
Neuroendocrinology; 2000 Jul; 72(1):46-56. PubMed ID: 10940738
[TBL] [Abstract][Full Text] [Related]
4. Induction of chinook salmon growth hormone promoter activity by the adenosine 3',5'-monophosphate (cAMP)-dependent pathway involves two cAMP-response elements with the CGTCA motif and the pituitary-specific transcription factor Pit-1.
Wong AO; Le Drean Y; Liu D; Hu ZZ; Du SJ; Hew CL
Endocrinology; 1996 May; 137(5):1775-84. PubMed ID: 8612514
[TBL] [Abstract][Full Text] [Related]
5. Protein kinase C regulation of prolactin gene expression in lactotroph cells: involvement in dopamine inhibition.
Chuang TT; Caccavelli L; Kordon C; Enjalbert A
Endocrinology; 1993 Feb; 132(2):832-8. PubMed ID: 7678802
[TBL] [Abstract][Full Text] [Related]
6. Somatostatin inhibits basal and vasoactive intestinal peptide-stimulated hormone release by different mechanisms in GH pituitary cells.
Dorflinger LJ; Schonbrunn A
Endocrinology; 1983 Nov; 113(5):1551-8. PubMed ID: 6138245
[TBL] [Abstract][Full Text] [Related]
7. Evidence that stimulatory dopamine receptors may be involved in the regulation of prolactin secretion.
Porter TE; Grandy D; Bunzow J; Wiles CD; Civelli O; Frawley LS
Endocrinology; 1994 Mar; 134(3):1263-8. PubMed ID: 8119166
[TBL] [Abstract][Full Text] [Related]
8. Thyrotrophin-releasing hormone, vasoactive intestinal peptide, prolactin-releasing peptide and dopamine regulation of prolactin secretion by different lactotroph morphological subtypes in the rat.
Christian HC; Chapman LP; Morris JF
J Neuroendocrinol; 2007 Aug; 19(8):605-13. PubMed ID: 17620102
[TBL] [Abstract][Full Text] [Related]
9. Somatostatin inhibits vasoactive intestinal peptide-stimulated cyclic adenosine monophosphate accumulation in GH pituitary cells.
Dorflinger LJ; Schonbrunn A
Endocrinology; 1983 Nov; 113(5):1541-50. PubMed ID: 6194974
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptor subtypes in clonal pituitary somatotrophs and gonadotrophs.
Rawlings SR; Piuz I; Schlegel W; Bockaert J; Journot L
Endocrinology; 1995 May; 136(5):2088-98. PubMed ID: 7720658
[TBL] [Abstract][Full Text] [Related]
11. Cyclic adenosine 3',5'-monophosphate activation of the rat prolactin promoter is restricted to the pituitary-specific cell type.
Keech CA; Jackson SM; Siddiqui SK; Ocran KW; Gutierrez-Hartmann A
Mol Endocrinol; 1992 Dec; 6(12):2059-70. PubMed ID: 1337142
[TBL] [Abstract][Full Text] [Related]
12. Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants.
Asghari V; Sanyal S; Buchwaldt S; Paterson A; Jovanovic V; Van Tol HH
J Neurochem; 1995 Sep; 65(3):1157-65. PubMed ID: 7643093
[TBL] [Abstract][Full Text] [Related]
13. Autoparacrine action of vasoactive intestinal peptide on dopaminergic control of prolactin secretion.
Balsa JA; Sánchez-Franco F; Lorenzo MJ; Pazos F; Lara JI; Cacicedo L
Endocrinology; 1996 Feb; 137(2):508-13. PubMed ID: 8593796
[TBL] [Abstract][Full Text] [Related]
14. Coupling of a cloned rat dopamine-D2 receptor to inhibition of adenylyl cyclase and prolactin secretion.
Albert PR; Neve KA; Bunzow JR; Civelli O
J Biol Chem; 1990 Feb; 265(4):2098-104. PubMed ID: 1688845
[TBL] [Abstract][Full Text] [Related]
15. Dependence of electrical activity and calcium influx-controlled prolactin release on adenylyl cyclase signaling pathway in pituitary lactotrophs.
Gonzalez-Iglesias AE; Jiang Y; Tomić M; Kretschmannova K; Andric SA; Zemkova H; Stojilkovic SS
Mol Endocrinol; 2006 Sep; 20(9):2231-46. PubMed ID: 16645040
[TBL] [Abstract][Full Text] [Related]
16. Somatostatin inhibits prolactin secretion by multiple mechanisms involving a site of action distal to increased cyclic adenosine 3',5'-monophosphate and elevated cytosolic Ca2+ in rat lactotrophs.
Bjøro T; Ostberg BC; Sand O; Torjesen PA; Penman E; Gordeladze JO; Iversen JG; Gautvik KM; Haug E
Acta Physiol Scand; 1988 Jul; 133(3):271-82. PubMed ID: 2906508
[TBL] [Abstract][Full Text] [Related]
17. Prolactin gene expression and secretion during pregnancy and lactation in the rat: role of dopamine and vasoactive intestinal peptide.
Escalada J; Cacicedo L; Ortego J; Melian E; Sánchez-Franco F
Endocrinology; 1996 Feb; 137(2):631-7. PubMed ID: 8593812
[TBL] [Abstract][Full Text] [Related]
18. Pituitary PRL secretion induced by tetraethylammonium is inhibited by dopamine through D2 receptors.
Wang X; Sato N; Greer MA; Falardeau P
Mol Cell Endocrinol; 1995 Aug; 112(2):153-7. PubMed ID: 7489818
[TBL] [Abstract][Full Text] [Related]
19. Transient dopaminergic inhibition of prolactin release from hybrid cells derived by fusion of normal rat pituitary and GH4C1 tumor cells.
Day RN; Hinkle PM
Endocrinology; 1988 May; 122(5):2165-73. PubMed ID: 3129281
[TBL] [Abstract][Full Text] [Related]
20. Influence of VIP on prolactinemia in turkey anterior pituitary cells: role of cAMP second messenger in VIP-induced prolactin gene expression.
Kang SW; Youngren OM; El Halawani ME
Regul Pept; 2002 Nov; 109(1-3):39-44. PubMed ID: 12409212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
